Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06782893Not ApplicableNot Yet Recruiting

Chronic COUGH Management in Interstitial Lung DisEase

Role: collaborator

NCT06742034Completed

Translation and Validation of the Visual Analysis of Swallowing Efficiency and Safety Into European Portuguese

Role: lead

NCT05737641Not ApplicableCompleted

Gastric Volume After Water or Jelly Ingestion

Role: lead

NCT06558435Completed

Validation of BRACS to European Portuguese

Role: lead

NCT05391646Not Yet Recruiting

Pulmonary Embolism Registry

Role: collaborator

NCT03534895Phase 4Unknown

Does the Preoperative Midazolam Dose Affect Postoperative Pain?

Role: collaborator

NCT01967290Not ApplicableCompleted

Stroke Wearable Operative Rehabilitation Device Impact Trial

Role: lead

All 7 trials loaded